ADAP
Adaptimmune Therapeutics
ADAP
ADAP
82 hedge funds and large institutions have $476M invested in Adaptimmune Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 12 closing their positions.
Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
22
Closed
12
Calls
$692K
Puts
$691K
Net Calls
+$1K
Net Calls Change
+$127K